Clinical Trials Directory

Trials / Terminated

TerminatedNCT01254734

Transoral Robotic Surgery in Treating Patients With Benign or Stage I-IV Head and Neck Cancer

Outcomes in Transoral Robotic Microsurgery for Head and Neck Tumors

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
7 (actual)
Sponsor
City of Hope Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

RATIONALE: Transoral robotic surgery (TORS) is a less invasive type of surgery for head and neck cancer and may have fewer side effects and improve recovery. PURPOSE: This clinical trial studies how transoral robotic surgery works in treating patients with benign or stage I-IV head and neck cancer.

Detailed description

PRIMARY OBJECTIVES: To conduct a pilot study at City of Hope (COH) which assesses the feasibility and safety of TORS (Transoral robotic surgery), including: total operative time, blood loss, hospitalization time, need to convert to an open procedure, intra-operative as well as post-operative complications. SECONDARY OBJECTIVES: I. To collect data on oncologic outcomes, disease free survival, local control rate and overall survival. II. To collect normative data regarding objective functional outcomes (FO) which may impact quality of life in patients undergoing TORS, including need for adjunctive procedures, such as gastrostomy tube placement and tracheostomy placement, and with regards to speech, swallowing function and pain, using patient-report outcomes instruments. OUTLINE: Patients undergo transoral robotic microsurgery. After completion of study treatment, patients are followed up periodically for 5 years.

Conditions

Interventions

TypeNameDescription
PROCEDUREtransoral robotic surgeryUndergo transoral robotic microsurgery
OTHERlaboratory biomarker analysisCorrelative studies
PROCEDUREquality-of-life assessmentAncillary studies

Timeline

Start date
2011-04-01
Primary completion
2014-11-01
Completion
2014-11-01
First posted
2010-12-07
Last updated
2014-11-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01254734. Inclusion in this directory is not an endorsement.